Ascend Wellness: Canaccord Lowers Target To US$10

On January 14th, after a number of press releases from Ascend Wellness Holdings, Inc. (CSE: AAWH.U), the company finally announced that it has filed a complaint against MedMen Enterprises Inc. (CSE: MMEN) and a preliminary injunction against them. This is in regards to Medmen’s unwillingness to transfer their New York license to Ascend.

Ascend Wellness currently has 8 analysts covering the stock with an average 12-month price target of US$13.19, or a 140% upside to the current stock price. Out of the 8 analysts, 2 have strong buy ratings while the other 6 have buy ratings. The street high sits at US$18, or a 228% upside to the current stock price, while the lowest price target sits at US$10.

In Canaccord Genuity’s update note, they reiterate their buy rating but lower their 12-month price target from US$13 to US$10 after reducing their Illinois and New Jersey estimates.

Canaccord has lowered its fourth-quarter estimates to $86.1 million in revenue and $19 million in adjusted EBITDA, putting the full-year estimates at $330 million and $78.7 million for revenue and adjusted EBITDA, respectively. They say that this revision primarily comes from “pricing pressure and a later-than-anticipated planting in IL, and a slower start to rec benefits in NJ.”

On the lawsuit, although Canaccord does not include any contributions from New York in their full-year estimates, they view that this asset is attractive and could possibly drive 5-10% of sales once integrated.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Still At 90:1, What If It Snaps Back To 15:1? | Glenn Jessome – Silver Tiger

Why This Gold Run Could Be Bigger | Roger Rosmus – Goliath Resources

Majors Don’t Want to Be Left Out of This Gold Run | Mike Bennett – Altamira Gold Corp

Recommended

Japan Gold Concludes Barrick Alliance After $23 Million In Spend, Discussions Ongoing With Potential New Partners

Sage Potash Outlines US$502 Million NPV For Flagship Sage Plains Project

Related News

Analysts Anticipate Advanced Micro Devices To Record $3.62 Billion In Q2 Revenues

Advanced Micro Devices (NASDAQ: AMD) will be reporting their second quarter financial results on July...

Tuesday, July 27, 2021, 12:49:00 PM

BMO Lowers IAMGOLD Price Target Following Westwood Layoffs

Yesterday, IAMGOLD Corp (TSX: IMG) announced a temporary workforce reduction to the tune of 437...

Tuesday, November 24, 2020, 12:03:00 PM

Canaccord Says Great Bear Royalties Is Next To Be Bought Out

With the many recently announced mergers and acquisitions in the gold producer space, Canaccord has...

Saturday, December 25, 2021, 02:09:00 PM

Green Thumb: Analysts Call For $207 Million In Q2 Revenue

Green Thumb Industries (CSE: GTII) announced that they will be reporting their second quarter financials...

Monday, August 9, 2021, 03:36:00 PM

Microsoft: Analysts Anticipate Q4 Earnings Per Share Of $2.29

Microsoft (NASDAQ: MSFT) will be reporting its fiscal fourth quarter financials today after markets close....

Tuesday, July 26, 2022, 10:57:00 AM